Diagnosis of Smoldering MS
Limitations of Current Therapeutic Options to Manage MS and Disability Progression
BTK Inhibitor Treatment Options for Smoldering MS
CME/CE credit is not available for this activity. Thank you to AstraZeneca for their support of this unrestricted medical educational grant.
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA